>

Vanderbilt School of Medicine Basic Sciences

Stomach Disease Research

The American Cancer Society’s estimates for stomach cancer (also known as gastric cancer) in the United States for 2026 are about 31,510 new cases of stomach cancer (17,900 in men and 13,610 in women), about 10,740 deaths from this type of cancer (6,360 men and 4,380 women). Stomach cancer accounts for about 1.5% of all new cancers diagnosed in the US each year.

Male stomach - human digestive system. (Adobe Stock image, by CLIPAREA.com)
Illustration of human torso with the stomach highlighted.

Stomach Disorders

Vanderbilt School of Medicine basic science researchers study stomach (gastric) cancer by uncovering the molecular and cellular mechanisms that drive tumor initiation, progression, and treatment resistance. Work spans cancer genetics and epigenetics, oncogenic signaling, metabolism, and interactions with the tumor microenvironment and immune system. Many labs use patient-derived samples, organoid cultures, and animal models to test how factors such as inflammation and infection contribute to disease and to identify biomarkers and drug targets. The overall goal is to translate mechanistic discoveries into improved detection strategies and more effective, durable therapies for patients with gastric cancer.